[1] R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2020, CA:A Cancer J. Clin. 70(1) (2020) 7-30. [2] S. Sindhwani, A.M. Syed, J. Ngai, B.R. Kingston, L. Maiorino, J. Rothschild, P. MacMillan, Y.W. Zhang, N.U. Rajesh, T. Hoang, J.L.Y. Wu, S. Wilhelm, A. Zilman, S. Gadde, A. Sulaiman, B. Ouyang, Z. Lin, L.S. Wang, M. Egeblad, W.C.W. Chan, The entry of nanoparticles into solid tumours, Nat. Mater. 19(5) (2020) 566- 575. [3] K.Q. Xu, Y. Cheng, J. Yan, Y.L. Feng, R.X. Zheng, X.Q. Wu, Y.J. Wang, P.P. Song, H. Y. Zhang, Polydopamine and ammonium bicarbonate coated and doxorubicin loaded hollow cerium oxide nanoparticles for synergistic tumor therapy, Nano Res. 12(12) (2019) 2947-2953. [4] M. Cagel, E. Grotz, E. Bernabeu, M.A. Moretton, D.A. Chiappetta, Doxorubicin:nanotechnological overviews from bench to bedside, Drug Discov. Today 22(2) (2017) 270-281. [5] J. Liu, Y.Z. Hu, H. Huang, Research progress of nanobodies in diagnosis and therapy of tumor, Chem. Ind. Eng. 30(4) (2013), 29-35, 54. [6] I. Ekladious, Y.L. Colson, M.W. Grinstaff, Polymer-drug conjugate therapeutics:advances, insights and prospects, Nat. Rev. Drug Discov. 18(4) (2019) 273-294. [7] F. Seidi, R. Jenjob, D. Crespy, Designing smart polymer conjugates for controlled release of payloads, Chem. Rev. 118(7) (2018) 3965-4036. [8] X. Zhang, X. Li, Q. You, X. Zhang, Prodrug strategy for cancer cell-specific targeting:A recent overview, Eur. J. Med. Chem. 139(2017) 542-563. [9] R. Walther, J. Rautio, A.N. Zelikin, Prodrugs in medicinal chemistry and enzyme prodrug therapies, Adv. Drug Deliv. Rev. 118(2017) 65-77. [10] A.G. Cheetham, R.W. Chakroun, W. Ma, H.G. Cui, Self-assembling prodrugs, Chem. Soc. Rev. 46(21) (2017) 6638-6663. [11] Q. Pei, X.L. Hu, X.H. Zheng, R. Xia, S. Liu, Z.G. Xie, X.B. Jing, Albumin-bound paclitaxel dimeric prodrug nanoparticles with tumor redox heterogeneitytriggered drug release for synergistic photothermal/chemotherapy, Nano Res. 12(4) (2019) 877-887. [12] W. Amly, R. Karaman, Recent updates in utilizing prodrugs in drug delivery (2013-2015), Expert Opin. Drug Deliv. 13(4) (2016) 571-591. [13] H.B. Chen, Z.J. Gu, H.W. An, C.Y. Chen, J. Chen, R. Cui, S.Q. Chen, W.H. Chen, X.S. Chen, X.Y. Chen, Z. Chen, B.Q. Ding, Q. Dong, Q. Fan, T. Fu, D.Y. Hou, Q. Jiang, H. T. Ke, X.Q. Jiang, G. Liu, S.P. Li, T. Li, Z. Liu, G.J. Nie, M. Ovais, D.W. Pang, N.S. Qiu, Y.Q. Shen, H.Y. Tian, C. Wang, H. Wang, Z.Q. Wang, H.P. Xu, J.F. Xu, X.L. Yang, S. Zhu, X.C. Zheng, X.Z. Zhang, Y.B. Zhao, W.H. Tan, X. Zhang, Y.L. Zhao, Precise nanomedicine for intelligent therapy of cancer, Sci. China Chem. 61(12) (2018) 1503-1552. [14] Y. Wang, S. Sun, Z. Zhang, D. Shi, Nanomaterials for cancer precision medicine, Adv. Mater. 30(17) (2018) e1705660. [15] J. Gao, X.Y. Lian, Z.P. Wei, B. Wang, H.Q. Li, X.W. Ren, Application of nanotechnology in the development of pharmaceutical preparations, Chem. Ind. Eng. 29(5) (2012) 64-69. [16] S. Tenzer, D. Docter, J. Kuharev, A. Musyanovych, V. Fetz, R. Hecht, F. Schlenk, D. Fischer, K. Kiouptsi, C. Reinhardt, K. Landfester, H. Schild, M. Maskos, S.K. Knauer, R.H. Stauber, Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology, Nat. Nanotechnol. 8(10) (2013) 772-781. [17] Z.Q. Shi, Q.Q. Li, L. Mei, pH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy, Chin. Chem. Lett. 31(6) (2020) 1345-1356. [18] C. Yang, T. Wu, Y. Qi, Z. Zhang, Recent advances in the application of vitamin E TPGS for drug delivery, Theranostics 8(2) (2018) 464-485. [19] W. Cheng, C.Y. Liang, L. Xu, G. Liu, N.S. Gao, W. Tao, L.Y. Luo, Y.X. Zuo, X.S. Wang, X.D. Zhang, X.W. Zeng, L. Mei, TPGS-functionalized polydopaminemodified mesoporous silica as drug nanocarriers for enhanced lung cancer chemotherapy against multidrug resistance, Small 13(29) (2017) e1700623. [20] D. Zhu, W. Tao, H. Zhang, G. Liu, T. Wang, L. Zhang, X. Zeng, L. Mei, Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer, Acta Biomater. 30(2016) 144-154. [21] X.W. Zeng, W. Tao, L. Mei, L.Q. Huang, C.Y. Tan, S.S. Feng, Cholic acidfunctionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer, Biomaterials 34(25) (2013) 6058-6067. [22] D. Pozzi, V. Colapicchioni, G. Caracciolo, S. Piovesana, A.L. Capriotti, S. Palchetti, S. De Grossi, A. Riccioli, H. Amenitsch, A. Laganà, Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids:From nanostructure to uptake in cancer cells, Nanoscale 6(5) (2014) 2782-2792. [23] W. Cheng, X. Zeng, H. Chen, Z. Li, W. Zeng, L. Mei, Y. Zhao, Versatile polydopamine platforms:synthesis and promising applications for surface modification and advanced nanomedicine, ACS Nano 13(8) (2019) 8537-8565. [24] B.W. Yang, Y. Chen, J.L. Shi, Reactive oxygen species (ROS)-based nanomedicine, Chem. Rev. 119(8) (2019) 4881-4985. [25] Z. Guo, J. Sui, M. Ma, J. Hu, Y. Sun, L. Yang, Y. Fan, X. Zhang, pH-Responsive charge switchable PEGylated e-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment, J. Control. Release 326(2020) 350-364. [26] Q. Jin, Y.Y. Deng, X.H. Chen, J. Ji, Rational design of cancer nanomedicine for simultaneous stealth surface and enhanced cellular uptake, ACS Nano 13(2) (2019) 954-977. [27] H.S. El-Sawy, A.M. Al-Abd, T.A. Ahmed, K.M. El-Say, V.P. Torchilin, Stimuliresponsive nano-architecture drug-delivery systems to solid tumor micromilieu:Past, present, and future perspectives, ACS Nano 12(11) (2018) 10636-10664. [28] R.Q. Yan, Y.X. Hu, F. Liu, S.X. Wei, D.Q. Fang, A.J. Shuhendler, H. Liu, H.Y. Chen, D.J. Ye, Activatable NIR fluorescence/MRI bimodal probes for in vivo imaging by enzyme-mediated fluorogenic reaction and self-assembly, J. Am. Chem. Soc. 141(26) (2019) 10331-10341. [29] S. He, S. Zhong, L. Xu, Y. Dou, Z. Li, F. Qiao, Y. Gao, X. Cui, Sonochemical fabrication of magnetic reduction-responsive alginate-based microcapsules for drug delivery, Int. J. Biol. Macromol. 155(2020) 42-49. [30] K. Kessenbrock, V. Plaks, Z. Werb, Matrix metalloproteinases:Regulators of the tumor microenvironment, Cell 141(1) (2010) 52-67. [31] A.C. Braun, M. Gutmann, R. Ebert, F. Jakob, H. Gieseler, T. Lühmann, L. Meinel, Matrix metalloproteinase responsive delivery of myostatin inhibitors, Pharm. Res. 34(1) (2017) 58-72. [32] Y. Chen, M.F. Su, Y.Q. Li, J.B. Gao, C. Zhang, Z. Cao, J.B. Zhou, J. Liu, Z.Z. Jiang, Enzymatic PEG-poly(amine-co-disulfide ester) nanoparticles as pH- and redox-responsive drug nanocarriers for efficient antitumor treatment, ACS Appl. Mater. Interfaces 9(36) (2017) 30519-30535. [33] M. Han, M.Y. Huang-Fu, W.W. Guo, N.N. Guo, J.J. Chen, H.N. Liu, Z.Q. Xie, M.T. Lin, Q.C. Wei, J.Q. Gao, MMP-2-sensitive HA end-conjugated poly(amidoamine) dendrimers via click reaction to enhance drug penetration into solid tumor, ACS Appl. Mater. Interfaces 9(49) (2017) 42459-42470. [34] W. Ke, Z. Zha, J.F. Mukerabigwi, W. Chen, Y. Wang, C. He, Z. Ge, Matrix metalloproteinase-responsive multifunctional peptide-linked amphiphilic block copolymers for intelligent systemic anticancer drug delivery, Bioconjug. Chem. 28(8) (2017) 2190-2198. [35] Y. Lv, C.R. Xu, X.M. Zhao, C.S. Lin, X. Yang, X.F. Xin, L. Zhang, C. Qin, X.P. Han, L. Yang, W. He, L.F. Yin, Nanoplatform assembled from a CD44-targeted prodrug and smart liposomes for dual targeting of tumor microenvironment and cancer cells, ACS Nano 12(2) (2018) 1519-1536. [36] Q. Yao, L.F. Kou, Y. Tu, L. Zhu, MMP-responsive 'smart' drug delivery and tumor targeting, Trends Pharmacol. Sci. 39(8) (2018) 766-781. [37] J. Pan, P.J. Li, Y. Wang, L. Chang, D. Wan, H. Wang, Active targeted drug delivery of MMP-2 sensitive polymeric nanoparticles, Chem. Commun. (Camb.) 54(79) (2018) 11092-11095. [38] L.L. Li, Q. Zeng, W.J. Liu, X.F. Hu, Y.S. Li, J. Pan, D. Wan, H. Wang, Quantitative analysis of caspase-1 activity in living cells through dynamic equilibrium of chlorophyll-based nano-assembly modulated photoacoustic signals, ACS Appl. Mater. Interfaces 8(28) (2016) 17936-17943. [39] X.M. Zhu, A. Tsend-Ayush, Z.Y. Yuan, J. Wen, J.X. Cai, S.F. Luo, J.X. Yao, J.X. Bian, L.F. Yin, J.P. Zhou, J. Yao, Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy, Int. J. Pharm. 529(1-2) (2017) 451-464. [40] J. Pan, D. Wan, Y.X. Bian, H.F. Sun, C. Zhang, F.M. Jin, Z.Q. Huang, J.L. Gong, Fluorescent hydroxyapatite-loaded biodegradable polymer nanoparticles with folate decoration for targeted imaging, AIChE J. 59(12) (2013) 4494- 4501. [41] C. Cui, Y.N. Xue, M. Wu, Y. Zhang, P. Yu, L. Liu, R.X. Zhuo, S.W. Huang, Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles, Biomaterials 34(15) (2013) 3858-3869. [42] N. Zhou, Z. Zhi, D.M. Liu, D.Q. Wang, Y.P. Shao, K. Yan, L.J. Meng, D.M. Yu, Acidresponsive and biologically degradable polyphosphazene nanodrugs for efficient drug delivery, ACS Biomater. Sci. Eng. 6(7) (2020) 4285-4293. [43] P. Chmielarz, M. Fantin, S. Park, A.A. Isse, A. Gennaro, A.J.D. Magenau, A. Sobkowiak, K. Matyjaszewski, Electrochemically mediated atom transfer radical polymerization (eATRP), Prog. Polym. Sci. 69(2017) 47-78. [44] T.F. Yang, C.N. Chen, M.C. Chen, C.H. Lai, H.F. Liang, H.W. Sung, Shellcrosslinked Pluronic L121 micelles as a drug delivery vehicle, Biomaterials 28(4) (2007) 725-734. [45] Y. Guo, M. Chu, S. Tan, S. Zhao, H. Liu, B.O. Otieno, X. Yang, C. Xu, Z. Zhang, Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance, Mol. Pharm. 11(1) (2014) 59-70. [46] J. Lu, Y. Huang, W. Zhao, Y. Chen, J. Li, X. Gao, R. Venkataramanan, S. Li, Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel, Mol. Pharm. 10(8) (2013) 2880-2890. [47] J.Y. Liu, Y. Pang, W. Huang, Z.Y. Zhu, X.Y. Zhu, Y.F. Zhou, D.Y. Yan, Redoxresponsive polyphosphate nanosized assemblies:A smart drug delivery platform for cancer therapy, Biomacromolecules 12(6) (2011) 2407-2415. [48] V.P. Torchilin, Targeted polymeric micelles for delivery of poorly soluble drugs, Cell. Mol. Life Sci. 61(19-20) (2004) 2549-2559. |